Elaboration de jonctions tunnel magnétiques à barrière SrTiO3 pour application bas RA

Ce travail de thèse porte sur l'élaboration et la caractérisation de jonctions tunnel magnétiques (JTM) polycristallines à barrière d'oxyde de titane de strontium, SrTiO3, qui se situe parmi les nouvelles barrières tunnel aux bandes interdites les plus étroites, recensées par la littérature. De telles barrières pourraient répondre à un besoin applicatif crucial : avoir un produit résistance x surface, RA, plus faible dans les JTM, ou à son corollaire, avoir une épaisseur de barrière plus forte à RA égal tout en conservant une magnétorésistance tunnel, TMR, élevée. De précédents travaux ont montré que le SrTiO3 présente une température de cristallisation inhabituellement basse (< 400C) lorsqu'il est déposé par pulvérisation par faisceau d'ions (IBS) ce qui peut le rendre compatible avec les électrodes magnétiques standards constitutives des JTM. Le dépôt par IBS restant une technique pour le moins exotique au regard de l'état de l'art des JTM, nous avons dans un premier temps élaboré des JTM à barrière d'oxyde de magnésium, MgO, matériau phare de la spintronique. Cette étude a permis de mettre en avant les paramètres spécifiques à cette technique de dépôt influant sur les propriétés de transport des JTM, notamment le type d'oxydation. Dans un second temps, nous avons réalisé des JTM CoFeB/SrTiO3/CoFeB par IBS à partir d'une cible céramique de SrTiO3, en nous inspirant du travail effectué sur le MgO. Les influences de plusieurs paramètres de dépôt, d'oxydation et de recuit ont été analysées, conduisant à deux tendances opposées avec des systèmes présentant soit à une TMR élevée (18 %), soit un RA faible (2.6 Ohm. m ). Des JTM SrTiO3 ont ensuite été nanostructurées pour la première fois et les tests électriques ont montré que les JTM ayant un bas RA présentaient un comportement ohmique alors que celles ayant une TMR élevée présentaient le comportement tunnel attendu. De plus, ces dernières présentent un claquage diélectrique intrinsèque à l'oxyde. En parallèle, des études microstructurales ont montré une qualité morphologique des JTM SrTiO3 semblable à celle des JTM MgO à l'état de l'art. Toutefois, ces observations n'ont pas permis de statuer sur le caractère cristallisé ou non des barrières en SrTiO3. Plusieurs pistes visant à déterminer la température de cristallisation du SrTiO3 dans la gamme des épaisseurs extraordinairement faibles des barrières tunnel ont été proposées.This work is focused on the development and the characterization of polycrystalline magnetic tunnel junctions (MTJ) with strontium titanium oxide barrier, SrTiO3, identified as a low band gap tunnel barrier by literature. Such barrier could fulfill the critical application requirement: having a lower resistance area product (RA) in MTJ, or its corollary, having a thicker barrier at constant RA, while keeping the tunnel magnetoresistance ratio (TMR) high enough. Former studies have shown that SrTiO3 deposited by ion beam sputtering (IBS) could crystallize at an unusual low temperature (< 400C) which could make it compatible with the magnetic layers of MTJs. In a first place, MTJs with a tunnel barrier made of a well known material in spintronics, namely MgO, were deposited. This preliminary work allowed us to highlight the specific parameters affecting the transport properties in MTJs deposited by IBS, including the oxidation type. In a second place, CoFeB/SrTiO3/CoFeB MTJs were developed using IBS and a SrTiO3 ceramic target, learning from our experience on MgO based MTJs. Many combinations of different parameters (including deposition, oxidation and annealing parameters) were explored, leading to two opposite tendencies with systems having either a high TMR (up to 18 %) or a low RA (down to 2.6 Ohm. m ). SrTiO3 based MTJs were then patterned for the first time and submitted to electrical tests. These tests showed that the MTJs having a low RA exhibited an ohmic behaviour while the MTJs having a large TMR showed the expected tunnel characteristics. Furthermore, the latter MTJs showed an intrinsic dielectric breakdown. In parallel, microstructural characterizations have shown that SrTiO3 based MTJs and MgO based MTJ were alike morphologically. Nevertheless, these observations alone were not enough to assess on the crystalline state of SrTiO3. Many possibilities/tracks aiming at determining the crystallisation temperature of SrTiO3, in the range of extremely low thicknesses used in MTJs, are identified.SAVOIE-SCD - Bib.électronique (730659901) / SudocGRENOBLE1/INP-Bib.électronique (384210012) / SudocGRENOBLE2/3-Bib.électronique (384219901) / SudocSudocFranceF

The use of Lorentz microscopy for the determination of magnetic reversal mechanism of exchange-biased Co30Fe70/NiMn bilayer

Lorentz transmission electron microscopy (LTEM) combined with in-situ magnetizing experiments is a powerful tool for the investigation of the magnetization of the reversal process at the micron scale. We have implemented this tool on a conventional transmission electron microscope (TEM) to study the exchange anisotropy of a polycrystalline Co35Fe65/NiMn bilayer. Semi-quantitative maps of the magnetic induction were obtained at different field values by the differential phase contrast (DPC) technique adapted for a TEM (SIDPC). The hysteresis loop of the bilayer has been calculated from the relative intensity of magnetic maps. The curve shows the appearance of an exchange-bias field reveals with two distinct reversal modes of the magnetization: the first path corresponds to a reversal by wall propagation when the applied field is parallel to the anisotropy direction whereas the second is a reversal by coherent rotation of magnetic moments when the field is applied antiparallel to unidirectional anisotropy direction

Thermal energy conversion by coupled shape memory and piezoelectric effects

International audienceThis work gives experimental evidence of a promising method of thermal-to-electric energy conversion by coupling shape memory effect (SME) and direct piezoelectric effect (DPE) for harvesting quasi-static ambient temperature variations. Two original prototypes of thermal energy harvesters have been fabricated and tested experimentally. The first is a hybrid laminated composite consisting of TiNiCu shape memory alloy (SMA) and macro fiber composite piezoelectric. This composite comprises 0.1 cm3 of active materials and harvests 75 µJ of energy for each temperature variation of 60 °C. The second prototype is a SME/DPE 'machine' which uses the thermally induced linear strains of the SMA to bend a bulk PZT ceramic plate through a specially designed mechanical structure. The SME/DPE 'machine' with 0.2 cm3 of active material harvests 90 µJ over a temperature increase of 35 °C (60 µJ when cooling). In contrast to pyroelectric materials, such harvesters are also compatible with both small and slow temperature variations

The Versatility of the Helicobacter pylori Vacuolating Cytotoxin VacA in Signal Transduction and Molecular Crosstalk

By modulating important properties of eukaryotic cells, many bacterial protein toxins highjack host signalling pathways to create a suitable niche for the pathogen to colonize and persist. Helicobacter pylori VacA is paradigm of pore-forming toxins which contributes to the pathogenesis of peptic ulceration. Several cellular receptors have been described for VacA, which exert different effects on epithelial and immune cells. The crystal structure of VacA p55 subunit might be important for elucidating details of receptor interaction and pore formation. Here we discuss the multiple signalling activities of this important toxin and the molecular crosstalk between VacA and other virulence factors

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

Treatment of rheumatoid arthritis (RA) may differ among rheumatologists and currently, clear and consensual international recommendations on RA treatment are not available. In this paper recommendations for the treatment of RA with synthetic and biological disease-modifying antirheumatic drugs (DMARDs) and glucocorticoids (GCs) that also account for strategic algorithms and deal with economic aspects, are described. The recommendations are based on evidence from five systematic literature reviews (SLRs) performed for synthetic DMARDs, biological DMARDs, GCs, treatment strategies and economic issues. The SLR-derived evidence was discussed and summarised as an expert opinion in the course of a Delphi-like process. Levels of evidence, strength of recommendations and levels of agreement were derived. Fifteen recommendations were developed covering an area from general aspects such as remission/low disease activity as treatment aim via the preference for methotrexate monotherapy with or without GCs vis-à-vis combination of synthetic DMARDs to the use of biological agents mainly in patients for whom synthetic DMARDs and tumour necrosis factor inhibitors had failed. Cost effectiveness of the treatments was additionally examined. These recommendations are intended to inform rheumatologists, patients and other stakeholders about a European consensus on the management of RA with DMARDs and GCs as well as strategies to reach optimal outcomes of RA, based on evidence and expert opinion

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

Recent insights in rheumatoid arthritis (RA) necessitated updating the European League Against Rheumatism (EULAR) RA management recommendations. A large international Task Force based decisions on evidence from 3 systematic literature reviews, developing 4 overarching principles and 12 recommendations (vs 3 and 14, respectively, in 2013). The recommendations address conventional synthetic (cs) disease-modifying antirheumatic drugs (DMARDs) (methotrexate (MTX), leflunomide, sulfasalazine); glucocorticoids (GC); biological (b) DMARDs (tumour necrosis factor (TNF)-inhibitors (adalimumab, certolizumab pegol, etanercept, golimumab, infliximab), abatacept, rituximab, tocilizumab, clazakizumab, sarilumab and sirukumab and biosimilar (bs) DMARDs) and targeted synthetic (ts) DMARDs (Janus kinase (Jak) inhibitors tofacitinib, baricitinib). Monotherapy, combination therapy, treatment strategies (treat-to-target) and the targets of sustained clinical remission (as defined by the American College of Rheumatology-(ACR)-EULAR Boolean or index criteria) or low disease activity are discussed. Cost aspects were taken into consideration. As first strategy, the Task Force recommends MTX (rapid escalation to 25 mg/week) plus short-term GC, aiming at >50% improvement within 3 and target attainment within 6 months. If this fails stratification is recommended. Without unfavourable prognostic markers, switching to—or adding—another csDMARDs (plus short-term GC) is suggested. In the presence of unfavourable prognostic markers (autoantibodies, high disease activity, early erosions, failure of 2 csDMARDs), any bDMARD (current practice) or Jak-inhibitor should be added to the csDMARD. If this fails, any other bDMARD or tsDMARD is recommended. If a patient is in sustained remission, bDMARDs can be tapered. For each recommendation, levels of evidence and Task Force agreement are provided, both mostly very high. These recommendations intend informing rheumatologists, patients, national rheumatology societies, hospital officials, social security agencies and regulators about EULAR's most recent consensus on the management of RA, aimed at attaining best outcomes with current therapies

2016 update of the EULAR recommendations for the management of early arthritis

Objectives: Since the 2007 recommendations for the management of early arthritis have been presented, considerable research has been published in the field of early arthritis, mandating an update of the 2007 EULAR recommendations for management of early arthritis. Methods: In accordance with the 2014 EULAR Standardised Operating Procedures, the expert committee pursued an approach that was based on evidence in the literature and on expert opinion. The committee involved 20 rheumatologists, 2 patients and 1 health professional representing 12 European countries. The group defined the focus of the expert committee and target population, formulated a definition of “management” and selected the research questions. A systematic literature research (SLR) was performed by 2 fellows with the help of a skilled librarian. A set of draft recommendations was proposed on the basis of the research questions and the results of the SLR. For each recommendation the categories of evidence were identified, the strength of recommendations was derived and the level of agreement was determined through a voting process. Results: The updated recommendations comprise 3 overarching principles and 12 recommendations for managing early arthritis. The selected statements involve the recognition of arthritis, referral, diagnosis, prognostication, treatment (information, education, pharmacological and non-pharmacological interventions), monitoring and strategy. Eighteen items were identified as relevant for future research. Conclusion: These recommendations provide rheumatologists, general practitioners, health professionals, patients and other stakeholders with an updated EULAR consensus on the entire management of early arthritis

Comparing Notes: Recording and Criticism

This chapter charts the ways in which recording has changed the nature of music criticism. It both provides an overview of the history of recording and music criticism, from the advent of Edison’s Phonograph to the present day, and examines the issues arising from this new technology and the consequent transformation of critical thought and practice